A detailed history of Covestor LTD transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Covestor LTD holds 1,007 shares of AXSM stock, worth $90,267. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,007
Previous 1,097 8.2%
Holding current value
$90,267
Previous $88,000 7.95%
% of portfolio
0.05%
Previous 0.06%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$65.72 - $80.5 $5,914 - $7,245
-90 Reduced 8.2%
1,007 $81,000
Q1 2024

May 10, 2024

BUY
$69.39 - $97.64 $75,982 - $106,915
1,095 Added 54750.0%
1,097 $88,000
Q2 2023

Aug 11, 2023

SELL
$58.41 - $90.35 $116 - $180
-2 Reduced 50.0%
2 $0
Q3 2022

Nov 14, 2022

SELL
$36.06 - $69.85 $108 - $209
-3 Reduced 42.86%
4 $0
Q2 2022

Aug 10, 2022

SELL
$21.74 - $46.75 $43 - $93
-2 Reduced 22.22%
7 $0
Q1 2022

May 13, 2022

SELL
$23.7 - $41.39 $47 - $82
-2 Reduced 18.18%
9 $0
Q4 2021

Feb 10, 2022

BUY
$30.7 - $43.36 $337 - $476
11 New
11 $0

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $3.84B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Covestor LTD Portfolio

Follow Covestor LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.